MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
40.86
-0.80
-1.92%
Opening 11:08 11/28 EST
OPEN
41.46
PREV CLOSE
41.66
HIGH
41.49
LOW
40.61
VOLUME
19.13K
TURNOVER
323.22K
52 WEEK HIGH
51.69
52 WEEK LOW
22.31
MARKET CAP
713.61M
P/E (TTM)
-9.1167
1D
5D
1M
3M
1Y
5Y
BRIEF-Ani Pharma Announces FDA Approval & Launch Of Fluoxetine Oral Solution Usp
Reuters · 12h ago
ANI Pharmaceuticals Announces The FDA Approval And Launch Of Fluoxetine Oral Solution USP
Benzinga · 12h ago
ANI Pharmaceuticals Says US FDA Approved Its Generic Version of Prozac
ANI Pharmaceuticals Says US FDA Approved Its Generic Version of Prozac
MT Newswires · 16h ago
This Biopharma 'Fits the Bill' as a Growth Play
With the economy looking like it is heading towards recession in 2023, reliable growth names with reasonable valuations are in short supply in the current market. ANI Pharmaceuticals is a roughly $650 million market cap specialty pharmaceutical company f...
TheStreet.com · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 11/16 13:08
ANI Pharmaceuticals launches generic antibiotic trimethoprim with FDA approval in bag
Seekingalpha · 11/16 12:05
ANI Pharmaceuticals Says US FDA Approves Trimethoprim Tablets
ANI Pharmaceuticals Says US FDA Approves Trimethoprim Tablets
MT Newswires · 11/16 07:07
ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates
ANI (ANIP) delivered earnings and revenue surprises of 10.34% and 6.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/09 13:05
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company that serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceuticals, including for diseases with unmet medical needs. The Company is focused on developing and manufacturing niche oncology products (anti-cancer). It has a commercial portfolio of over 101 products with a variety of indications and a portfolio of pipeline products. The Company owns the facility, which includes oral solid dose and liquid manufacturing and packaging, warehouse facilities, analytical, stability, and microbiological laboratory space, and employee office and mechanical space. It also owns a manufacturing facility that includes oral solid dose manufacturing and packaging for pharmaceutical products. Its four pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, one is located in East Windsor, New Jersey and one is located in Oakville, Ontario.

Webull offers kinds of ANI Pharmaceuticals Inc stock information, including NASDAQ:ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.